146 related articles for article (PubMed ID: 38763334)
21. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
[TBL] [Abstract][Full Text] [Related]
22. Telomere Maintenance Mechanisms in Cancer.
Gaspar TB; Sá A; Lopes JM; Sobrinho-Simões M; Soares P; Vinagre J
Genes (Basel); 2018 May; 9(5):. PubMed ID: 29751586
[TBL] [Abstract][Full Text] [Related]
23. Selective Elimination of Osteosarcoma Cell Lines with Short Telomeres by Ataxia Telangiectasia and Rad3-Related Inhibitors.
Goncalves T; Zoumpoulidou G; Alvarez-Mendoza C; Mancusi C; Collopy LC; Strauss SJ; Mittnacht S; Tomita K
ACS Pharmacol Transl Sci; 2020 Dec; 3(6):1253-1264. PubMed ID: 33344901
[TBL] [Abstract][Full Text] [Related]
24. Alternative Lengthening of Telomeres: DNA Repair Pathways Converge.
Sobinoff AP; Pickett HA
Trends Genet; 2017 Dec; 33(12):921-932. PubMed ID: 28969871
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma.
Else T; Giordano TJ; Hammer GD
J Clin Endocrinol Metab; 2008 Apr; 93(4):1442-9. PubMed ID: 18198226
[TBL] [Abstract][Full Text] [Related]
26. The first molecular details of ALT in human tumor cells.
Muntoni A; Reddel RR
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R191-6. PubMed ID: 16244317
[TBL] [Abstract][Full Text] [Related]
27. How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
Akter J; Kamijo T
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439779
[TBL] [Abstract][Full Text] [Related]
28. SLX4IP Promotes Telomere Maintenance in Androgen Receptor-Independent Castration-Resistant Prostate Cancer through ALT-like Telomeric PML Localization.
Mangosh TL; Awadallah WN; Grabowska MM; Taylor DJ
Mol Cancer Res; 2021 Feb; 19(2):301-316. PubMed ID: 33188147
[TBL] [Abstract][Full Text] [Related]
29. ALTernative Telomere Maintenance and Cancer.
Dilley RL; Greenberg RA
Trends Cancer; 2015 Oct; 1(2):145-156. PubMed ID: 26645051
[TBL] [Abstract][Full Text] [Related]
30. Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanisms.
Johnson JE; Gettings EJ; Schwalm J; Pei J; Testa JR; Litwin S; von Mehren M; Broccoli D
Cancer Res; 2007 Oct; 67(19):9221-8. PubMed ID: 17909028
[TBL] [Abstract][Full Text] [Related]
31. Alternative paths to telomere elongation.
Lee JJ; Lee J; Lee H
Semin Cell Dev Biol; 2021 May; 113():88-96. PubMed ID: 33293233
[TBL] [Abstract][Full Text] [Related]
32. Telomere maintenance mechanism dysregulation serves as an early predictor of adjuvant therapy response and a potential therapeutic target in human cancers.
Zhang Y; Luo S; Jia Y; Zhang X
Int J Cancer; 2022 Jul; 151(2):313-327. PubMed ID: 35342938
[TBL] [Abstract][Full Text] [Related]
33. Alternative mechanisms of telomere lengthening: permissive mutations, DNA repair proteins and tumorigenic progression.
Gocha ARS; Harris J; Groden J
Mutat Res; 2013; 743-744():142-150. PubMed ID: 23219603
[TBL] [Abstract][Full Text] [Related]
34. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
35. Changes in the Expression of Pre-Replicative Complex Genes in hTERT and ALT Pediatric Brain Tumors.
Idilli AI; Pagani F; Kerschbamer E; Berardinelli F; Bernabé M; Cayuela ML; Piazza S; Poliani PL; Cusanelli E; Mione MC
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32331249
[No Abstract] [Full Text] [Related]
36. Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression.
Costa A; Daidone MG; Daprai L; Villa R; Cantù S; Pilotti S; Mariani L; Gronchi A; Henson JD; Reddel RR; Zaffaroni N
Cancer Res; 2006 Sep; 66(17):8918-24. PubMed ID: 16951210
[TBL] [Abstract][Full Text] [Related]
37. The role of recombination in telomere length maintenance.
Royle NJ; Méndez-Bermúdez A; Gravani A; Novo C; Foxon J; Williams J; Cotton V; Hidalgo A
Biochem Soc Trans; 2009 Jun; 37(Pt 3):589-95. PubMed ID: 19442255
[TBL] [Abstract][Full Text] [Related]
38. Alternative lengthening of telomeres does exist in various canine sarcomas.
Kreilmeier T; Sampl S; Deloria AJ; Walter I; Reifinger M; Hauck M; Borst LB; Holzmann K; Kleiter M
Mol Carcinog; 2017 Mar; 56(3):923-935. PubMed ID: 27585244
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
Pompili L; Leonetti C; Biroccio A; Salvati E
J Exp Clin Cancer Res; 2017 Dec; 36(1):189. PubMed ID: 29273061
[TBL] [Abstract][Full Text] [Related]
40. Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma.
Minasi S; Baldi C; Gianno F; Antonelli M; Buccoliero AM; Pietsch T; Massimino M; Buttarelli FR
Childs Nerv Syst; 2021 Mar; 37(3):809-818. PubMed ID: 33128602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
